134 related articles for article (PubMed ID: 38704114)
1. A biomimetic ion channel shortens the QT interval of type 2 long QT syndrome through efficient transmembrane transport of potassium ions.
Sun S; Xu Z; Lin Z; Chen W; Zhang Y; Yan M; Ren S; Liu Q; Zhu H; Tian B; Zhang J; Zhang W; Jiang S; Sheng C; Ge J; Chen F; Dong Z
Acta Biomater; 2024 Jun; 181():391-401. PubMed ID: 38704114
[TBL] [Abstract][Full Text] [Related]
2. Molecular biology of the long QT syndrome: impact on management.
Priori SG; Napolitano C; Paganini V; Cantù F; Schwartz PJ
Pacing Clin Electrophysiol; 1997 Aug; 20(8 Pt 2):2052-7. PubMed ID: 9272507
[TBL] [Abstract][Full Text] [Related]
3. The long QT syndrome: new diagnostic and therapeutic approach in the era of molecular biology.
Priori SG; Cantù F; Schwartz PJ
Schweiz Med Wochenschr; 1996 Oct; 126(41):1727-31. PubMed ID: 8893413
[TBL] [Abstract][Full Text] [Related]
4. A computational analysis of the effect of sevoflurane in a human ventricular cell model of long QT syndrome: Importance of repolarization reserve in the QT-prolonging effect of sevoflurane.
Kojima A; Fukushima Y; Itoh H; Imoto K; Matsuura H
Eur J Pharmacol; 2020 Sep; 883():173378. PubMed ID: 32710951
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenomics of anesthetic drugs in transgenic LQT1 and LQT2 rabbits reveal genotype-specific differential effects on cardiac repolarization.
Odening KE; Hyder O; Chaves L; Schofield L; Brunner M; Kirk M; Zehender M; Peng X; Koren G
Am J Physiol Heart Circ Physiol; 2008 Dec; 295(6):H2264-72. PubMed ID: 18835916
[TBL] [Abstract][Full Text] [Related]
6. Mexiletine Shortens the QT Interval in Patients With Potassium Channel-Mediated Type 2 Long QT Syndrome.
Bos JM; Crotti L; Rohatgi RK; Castelletti S; Dagradi F; Schwartz PJ; Ackerman MJ
Circ Arrhythm Electrophysiol; 2019 May; 12(5):e007280. PubMed ID: 31006312
[TBL] [Abstract][Full Text] [Related]
7. Patients With Long-QT Syndrome Caused by Impaired
Hyltén-Cavallius L; Iepsen EW; Wewer Albrechtsen NJ; Svendstrup M; Lubberding AF; Hartmann B; Jespersen T; Linneberg A; Christiansen M; Vestergaard H; Pedersen O; Holst JJ; Kanters JK; Hansen T; Torekov SS
Circulation; 2017 May; 135(18):1705-1719. PubMed ID: 28235848
[TBL] [Abstract][Full Text] [Related]
8. Sinus node function and ventricular repolarization during exercise stress test in long QT syndrome patients with KvLQT1 and HERG potassium channel defects.
Swan H; Viitasalo M; Piippo K; Laitinen P; Kontula K; Toivonen L
J Am Coll Cardiol; 1999 Sep; 34(3):823-9. PubMed ID: 10483966
[TBL] [Abstract][Full Text] [Related]
9. A molecular basis for the therapy of the long QT syndrome.
Priori SG; Napolitano C; Schwartz PJ
Arch Mal Coeur Vaiss; 1996 Sep; 89(9):1185-7. PubMed ID: 8952843
[TBL] [Abstract][Full Text] [Related]
10. Spatial correlation of action potential duration and diastolic dysfunction in transgenic and drug-induced LQT2 rabbits.
Odening KE; Jung BA; Lang CN; Cabrera Lozoya R; Ziupa D; Menza M; Relan J; Franke G; Perez Feliz S; Koren G; Zehender M; Bode C; Brunner M; Sermesant M; Föll D
Heart Rhythm; 2013 Oct; 10(10):1533-41. PubMed ID: 23892340
[TBL] [Abstract][Full Text] [Related]
11. Effects of a K(+) channel opener to reduce transmural dispersion of repolarization and prevent torsade de pointes in LQT1, LQT2, and LQT3 models of the long-QT syndrome.
Shimizu W; Antzelevitch C
Circulation; 2000 Aug; 102(6):706-12. PubMed ID: 10931813
[TBL] [Abstract][Full Text] [Related]
12. Thapsigargin selectively rescues the trafficking defective LQT2 channels G601S and F805C.
Delisle BP; Anderson CL; Balijepalli RC; Anson BD; Kamp TJ; January CT
J Biol Chem; 2003 Sep; 278(37):35749-54. PubMed ID: 12837749
[TBL] [Abstract][Full Text] [Related]
13. Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy.
Schwartz PJ; Priori SG; Locati EH; Napolitano C; Cantù F; Towbin JA; Keating MT; Hammoude H; Brown AM; Chen LS; Colatsky TJ
Circulation; 1995 Dec; 92(12):3381-6. PubMed ID: 8521555
[TBL] [Abstract][Full Text] [Related]
14. Hyperphosphorylation of RyRs underlies triggered activity in transgenic rabbit model of LQT2 syndrome.
Terentyev D; Rees CM; Li W; Cooper LL; Jindal HK; Peng X; Lu Y; Terentyeva R; Odening KE; Daley J; Bist K; Choi BR; Karma A; Koren G
Circ Res; 2014 Nov; 115(11):919-28. PubMed ID: 25249569
[TBL] [Abstract][Full Text] [Related]
15. Promise and Potential Peril With Lumacaftor for the Trafficking Defective Type 2 Long-QT Syndrome-Causative Variants, p.G604S, p.N633S, and p.R685P, Using Patient-Specific Re-Engineered Cardiomyocytes.
O'Hare BJ; John Kim CS; Hamrick SK; Ye D; Tester DJ; Ackerman MJ
Circ Genom Precis Med; 2020 Oct; 13(5):466-475. PubMed ID: 32940533
[TBL] [Abstract][Full Text] [Related]
16. Bupivacaine destabilizes action potential duration in cellular and computational models of long QT syndrome 1.
Schwoerer AP; Zenouzi R; Ehmke H; Friederich P
Anesth Analg; 2011 Dec; 113(6):1365-73. PubMed ID: 22003215
[TBL] [Abstract][Full Text] [Related]
17. Mechanistic basis for type 2 long QT syndrome caused by KCNH2 mutations that disrupt conserved arginine residues in the voltage sensor.
McBride CM; Smith AM; Smith JL; Reloj AR; Velasco EJ; Powell J; Elayi CS; Bartos DC; Burgess DE; Delisle BP
J Membr Biol; 2013 May; 246(5):355-64. PubMed ID: 23546015
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of gefitinib-induced QT prolongation.
Jie LJ; Li YD; Zhang HQ; Mao L; Xie HB; Zhou FG; Zhou TL; Xie D; Lin JL; Li GY; Cai BN; Zhang YH; Wang Y
Eur J Pharmacol; 2021 Nov; 910():174441. PubMed ID: 34474028
[TBL] [Abstract][Full Text] [Related]
19. Electrophysiological phenotype in the LQTS mutations Y111C and R518X in the KCNQ1 gene.
Diamant UB; Vahedi F; Winbo A; Rydberg A; Stattin EL; Jensen SM; Bergfeldt L
J Appl Physiol (1985); 2013 Nov; 115(10):1423-32. PubMed ID: 24052033
[TBL] [Abstract][Full Text] [Related]
20. Long QT syndrome: cellular basis and arrhythmia mechanism in LQT2.
January CT; Gong Q; Zhou Z
J Cardiovasc Electrophysiol; 2000 Dec; 11(12):1413-8. PubMed ID: 11196567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
